Human psychopharmacology
-
Human psychopharmacology · Dec 2003
Randomized Controlled Trial Comparative Study Clinical TrialMilnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
New, better tolerated and faster treatments for depression are needed. Patients are understandably unhappy with having to wait 3 to 4 weeks for a response to an antidepressant, while experiencing side effects almost immediately. This frequently has an adverse effect on compliance and engagement with treatment. ⋯ The milnacipran and pindolol combination is safe, well tolerated and efficacious in major depression, and represents a rational strategy for the possible acceleration or potentiation of antidepressant action.